Compass Therapeutics (CMPX) Insider Trading & Ownership → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free CMPX Stock Alerts $1.54 -0.07 (-4.35%) (As of 05/15/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.00%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$21.36 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$62,561.23 Get CMPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CMPX Insider Buying and Selling by Quarter Ad Manward PressAmazon's betting big on this unknown AI companyAmazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company Compass Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/10/2023Thomas J SchuetzCEOBuy10,000$3.37$33,700.00 2/27/2023Thomas J SchuetzCEOBuy20,000$3.98$79,600.00 2/15/2023Thomas J SchuetzCEOBuy20,000$3.86$77,200.00 1/31/2023Thomas J SchuetzCEOBuy20,000$4.05$81,000.00 1/24/2023Thomas J SchuetzCEOBuy20,000$4.19$83,800.00 11/25/2022Vered Bisker-LeibCOOSell2$4.36$8.72 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/22/2022Vered Bisker-LeibCOOSell14,929$4.19$62,552.51 11/8/2022Orbimed Advisors LlcDirectorBuy402,000$3.21$1,290,420.00 9/28/2022Thomas J SchuetzCEOBuy10,000$2.32$23,200.00 9/26/2022Thomas J SchuetzCEOBuy15,000$2.27$34,050.00 8/10/2022Thomas J SchuetzCEOBuy15,000$2.64$39,600.00 8/1/2022Thomas J SchuetzCEOBuy15,000$2.58$38,700.00 6/21/2022Thomas J SchuetzCEOBuy20,000$2.80$56,000.00 6/16/2022Thomas J SchuetzCEOBuy20,000$2.34$46,800.00 6/13/2022Thomas J SchuetzCEOBuy30,000$2.29$68,700.00 6/6/2022Thomas J SchuetzCEOBuy30,000$2.83$84,900.00 6/1/2022Thomas J SchuetzCEOBuy20,000$3.03$60,600.00 5/26/2022Thomas J SchuetzCEOBuy20,000$3.04$60,800.00 5/23/2022Thomas J SchuetzCEOBuy18,355$2.72$49,925.60 5/13/2022Carl L GordonDirectorBuy30,722$2.49$76,497.78 5/11/2022Carl L GordonDirectorBuy64,700$1.79$115,813.00 5/10/2022Thomas J SchuetzCEOBuy27,836$1.80$50,104.80 5/9/2022Orbimed Advisors LlcDirectorBuy90,712$1.56$141,510.72 5/6/2022Orbimed Advisors LlcDirectorBuy10,200$1.63$16,626.00 11/4/2021Carl L GordonDirectorBuy5,357,143$3.50$18,750,000.50 (Data available from 1/1/2013 forward) CMPX Insider Trading Activity - Frequently Asked Questions Who is on Compass Therapeutics's Insider Roster? The list of insiders at Compass Therapeutics includes Carl L Gordon, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX. What percentage of Compass Therapeutics stock is owned by insiders? 30.00% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings. Which Compass Therapeutics insiders have been buying company stock? The following insiders have purchased CMPX shares in the last 24 months: Orbimed Advisors Llc ($1,290,420.00), and Thomas J Schuetz ($918,575.60). How much insider buying is happening at Compass Therapeutics? Insiders have purchased a total of 705,355 CMPX shares in the last 24 months for a total of $2,208,995.60 bought. Which Compass Therapeutics insiders have been selling company stock? The following insider sold CMPX shares in the last 24 months: Vered Bisker-Leib ($62,561.23). How much insider selling is happening at Compass Therapeutics? Insiders have sold a total of 14,931 Compass Therapeutics shares in the last 24 months for a total of $62,561.23 sold. More Insider Trading Tools from MarketBeat Related Companies: PCB Insider Trades MGX Insider Trades AGEN Insider Trades IPSC Insider Trades ADVM Insider Trades KOD Insider Trades CHRS Insider Trades FENC Insider Trades INMB Insider Trades ABOS Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:CMPX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
